Atopic Eczema Clinical Trial
Official title:
Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children: A Small, Randomized, Split Body, Controlled, Blinded Pilot Study
The aim of this small pilot study is to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with atopic eczema. This is a split body, controlled, randomized and physician blinded pilot study, of children with atopic eczema with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient is to be applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. Severity and area of the eczema spots is evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00484003 -
A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis
|
Phase 4 | |
Recruiting |
NCT06230991 -
A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema
|
N/A | |
Completed |
NCT05454722 -
A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.
|
N/A | |
Completed |
NCT01854580 -
Evaluation of an Integrated Care Project
|
||
Completed |
NCT00555178 -
Regulatory T Cells (Tregs) in Polymorphic Light Eruption
|
N/A | |
Completed |
NCT00559546 -
Montelukast as a Controller of Atopic Syndrome
|
Phase 4 | |
Completed |
NCT00224432 -
Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis
|
N/A | |
Active, not recruiting |
NCT03143504 -
A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study
|
||
Active, not recruiting |
NCT03409367 -
A Community-based Assessment of Skin Care, Allergies, and Eczema
|
N/A | |
Not yet recruiting |
NCT06453512 -
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
|
N/A | |
Completed |
NCT00826592 -
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
|
N/A | |
Completed |
NCT00576238 -
Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser
|
Phase 3 | |
Active, not recruiting |
NCT05590585 -
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
|
Phase 4 | |
Completed |
NCT01119313 -
Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema
|
Phase 2 | |
Completed |
NCT00676884 -
A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema
|
Phase 2 | |
Recruiting |
NCT03270566 -
Softened Water for Eczema Prevention Pilot Trial
|
N/A | |
Completed |
NCT02300701 -
Role of Anti-IgE in Severe Childhood Eczema
|
Phase 4 | |
Completed |
NCT04114097 -
The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover
|
Phase 4 | |
Completed |
NCT02915146 -
Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema
|
N/A | |
Recruiting |
NCT00771121 -
Effect of Moisturizing Creams on Skin Barrier Function
|
Phase 4 |